LON:IBT International Biotechnology (IBT) Share Price, News & Analysis GBX 664 -2.00 (-0.30%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range 664▼ 684.9950-Day Range 634▼ 70852-Week Range 548▼ 720Volume103,367 shsAverage Volume62,024 shsMarket Capitalization£245.41 millionP/E Ratio1,383.33Dividend Yield4.37%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades Get International Biotechnology alerts: Email Address Ad Porter & CompanyThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.So go here now to read my new report The Big AI Die-Up… while you still can. About International Biotechnology Stock (LON:IBT)International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.Read More IBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBT Stock News HeadlinesSeptember 4 at 10:33 PM | cbsnews.comTeamsters president says he hasn't endorsed Kamala Harris yet because "you don't hire someone unless you give them an interview"August 27, 2024 | reuters.comIndia's Bharat Biotech to launch oral cholera vaccine amid global shortageSeptember 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.August 3, 2024 | lse.co.ukInt.biotech. Regulatory NewsApril 13, 2024 | nytimes.comBiotech Exec Gets 7 Years in Prison for False Claims About Rapid Covid-19 TestApril 3, 2024 | uk.finance.yahoo.comFidelity Asian Values Plc - Directorate ChangeApril 3, 2024 | bizjournals.comBioConsortia raises $15 million to expand Davis lab, field trialsApril 2, 2024 | msn.comBharat Biotech, Bilthoven Biologicals join forces to fortify global polio eradication effortsSeptember 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.March 26, 2024 | gurufocus.comInternational Biotechnology Trust PLC Introductory Video TranscriptMarch 25, 2024 | msn.comI'm a fund manager: Why biotech investor Ailsa Craig thinks rate cuts will spark a reboundMarch 9, 2024 | news.yahoo.comOur go-to guide for races in Livingston CountyFebruary 6, 2024 | investing.comInternational Biotechnology Trust plc (IBT)January 30, 2024 | marketwatch.comAvrobio to Merge With Tectonic Therapeutic in All-Stock DealJanuary 10, 2024 | benzinga.comComparing Biogen With Industry Competitors In Biotechnology IndustryJanuary 6, 2024 | reuters.comTrump meets Teamsters chief as union weighs presidential raceJanuary 4, 2024 | msn.comThis young biotech fund is worth a punt at a 25pc discountJanuary 3, 2024 | msn.comExclusive: Thermo Fisher halts DNA collection kit sales in TibetSee More Headlines Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 8/23 Dividend7/25/2024Dividend Payable8/23/2024Today9/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:IBT CUSIPN/A CIKN/A Webwww.ibtplc.com Phone44 20 7421 7070FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.48 Trailing P/E Ratio1,383.33 Forward P/E Ratio697.48 P/E GrowthN/ANet Income£18.19 million Net Margins75.33% Pretax MarginN/A Return on Equity6.25% Return on Assets3.57% Debt Debt-to-Equity Ratio9.66 Current Ratio0.46 Quick Ratio0.32 Sales & Book Value Annual Sales£24.14 million Price / Sales10.17 Cash FlowGBX 4.26 per share Price / Cash Flow155.74 Book ValueGBX 749 per share Price / Book0.89Miscellaneous Outstanding Shares36,960,000Free FloatN/AMarket Cap£245.41 million OptionableNot Optionable Beta0.21 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Catherine Elizabeth Bingham M.B.A. (Age 58)Managing Partner Claire JacksonCompany SecretaryDr. Carl Harald JansonLead Investment ManagerKey CompetitorsJPMorgan Elect plc - Managed GrowthLON:JPEImpax Environmental MarketsLON:IEMRuffer InvestmentLON:RICANinety One GroupLON:N91BlackRock World Mining TrustLON:BRWMView All CompetitorsInsidersGillian ElcockBought 1,407 shares on 7/24/2024Total: £997,563.00 ($709.00/share)Caroline GulliverBought 2,500 shares on 11/7/2023Total: £1.43 M ($573.00/share)View All Insider Transactions IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed this year? International Biotechnology's stock was trading at GBX 642 at the beginning of the year. Since then, IBT stock has increased by 3.4% and is now trading at GBX 664. View the best growth stocks for 2024 here. How do I buy shares of International Biotechnology? Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of International Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Oxford Pharmascience Group (OXP), Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Phoenix Group (PHNX). This page (LON:IBT) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.